Biggest News Aggregation in the World
📰 Immunic News

Immunic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immunic. Real-time updates on events, politics, business and more.

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com

StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […]
United States Immunic Inc Innovis Asset Management Sweet Financial Partners Acadian Asset Management Sierra Summit Advisors
Source: wkrb13.com

Immunic (IMUX) to Release Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]
United States Jpmorgan Chase Co American Century Companies Inc Sigma Securities Immunic Inc Charles Schwab Investment Management Inc

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]
Leerink Partnrs Vontobel Holding Ltd Gratus Capital Innovis Asset Management Immunic Inc Acadian Asset Management

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Immunic (NASDAQ:IMUX) PT Raised to $7.00 at Wedbush

Immunic (NASDAQ:IMUX – Free Report) had its price target lifted by Wedbush from $5.00 to $7.00 in a research note published on Tuesday, MarketBeat Ratings reports. The firm currently has an outperform rating on the stock. Separately, StockNews.com initiated coverage on Immunic in a research note on Thursday, October 5th. They issued a sell rating […]
Sigma Securities Schonfeld Strategic Advisors Immunic Inc Immunic Company Profile Wolverine Trading Blackrock Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science